INmune Bio Inc. Announces Second Quarter 2024 Results and Provides Business Update

Company to Host Conference Call Today, August 1, at 4:30pm ET

BOCA RATON, Fla., Aug. 01, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company developing treatments that harness the patient’s innate immune system to fight disease, today announces its financial results for the quarter ended June 30, 2024 and provides a business update.